Lynexa Trademark Details
Word Mark | Lynexa |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Current Owner
Dupont Pharmaceuticals Company of Wilmington, DE
View all trademarks for Dupont Pharmaceuticals CompanySerial Number | 76161785 |
---|---|
Status Date | Sunday, October 10, 2004 |
Filing Date | Sunday, October 10, 2004 |
Attorney | Blair Q Ferguson |
Correspondent
G. Mathew Lombard
Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Bristol-Myers Squibb Company
345 Park Avenue
New York NY 10154
Case File Statements
Goods & Services | Pharmaceutical Preparations, for the Treatment of Cardiovascular Diseases, Central Nervous System Diseases, Cancer, Inflammation and Inflammatory Diseases, Respiratory and Infectious Diseases and for Diagnostic Imaging |
---|
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Friday, November 17, 2000 |
Primary Code | 005 |
Trademark Timeline
-
Nov 08 2000Trademark application filed with USPTO
-
Apr 04 2001Assigned To Examiner
-
Apr 09 2001Approved For Pub - Principal Register
-
Jul 04 2001Notice of Publication
-
Jul 17 2001Published For Opposition
-
Oct 09 2001Noa Mailed - Sou Required From Applicant
-
Feb 11 2002Extension 1 Filed
-
Feb 28 2002Extension 1 Granted
-
Jul 24 2002Teas Change of Correspondence Received
-
Sep 12 2002Extension 2 Granted
-
Sep 12 2002Extension 2 Filed
-
Sep 12 2002Teas Extension Received
-
Mar 28 2003Extension 3 Filed
-
Mar 28 2003Teas Extension Received
-
May 14 2003Extension 3 Granted
-
Oct 08 2003Extension 4 Filed
-
Oct 08 2003Teas Extension Received
-
Oct 16 2003Extension 4 Granted
-
Mar 16 2004Extension 5 Granted
-
Mar 16 2004Extension 5 Filed
-
Mar 16 2004Teas Extension Received
-
Apr 26 2004Assigned To Examiner
-
Jul 06 2004Case File In Ticrs
-
Feb 03 2005Abandonment Notice Mailed - No Use Statement Filed
-
Feb 03 2005Abandonment - No Use Statement Filed